Brown adipose tissue may play a role in glucose metabolism, and thus influence the risk of developing diabetes.
Read More »Yearly Archives: 2019
ESC Guidelines Updated for Managing CVD in Diabetes
Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA tx
Read More »Menstrual Cycles More Varied Than Previously Thought
Tracking basal body temperature and other parameters improves accuracy of ovulation detection
Read More »Metabolic Surgery May Reduce CV Risk in T2DM With Obesity
Reduction seen in primary end point and seven prespecified secondary outcomes, including mortality
Read More »Sept. 3, 2019
Last week I was working on a project, and it seemed like I was spending my whole day looking at spreadsheets and pivot tables. As the day went by I kept making the numbers larger to make it easier to read, and finally I had to give up for a …
Read More »Patient Injection Mistakes
I visited a housebound patient who had uncontrolled blood glucose, in spite of her physician having increased her insulin dose over a period of two weeks to twice her previous dose. The physician requested that I ask in depth about any factors that might be causing her to need so much more insulin.
Read More »Provider Empathy Linked to Cardiovascular and Mortality Risk in Diabetes
This data supports previous research that linked provider empathy with clinical outcomes in patients with diabetes.
Read More »Pioglitazone or Sulfonylureas in Patients with Pretreatment Cardiovascular Risk
Cardiovascular risks in patients with type 2 diabetes using sulfonylureas vs. pioglitazone: personalized care approach.
Read More »Stillbirth Risk In Pregnant Women With Diabetes
Body mass index and glucose control play a role in the higher stillbirth risk for pregnant women with diabetes.
Read More »August 2019 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Cerebrovascular Risk …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.